Intelligence · Drug directory
EMA-Approved Drugs Directory
European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
Quick answer
EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
-
moroctocog alfa
REFACTO AF
B02BD02 -
mosunetuzumab
LUNSUMIO
L01FX25 -
mycobacterium tuberculosis derived antigens (rdesat-6 / rcfp-10)
SIILTIBCY
V04CF -
naldemedine
RIZMOIC
A06AH05 -
nalmefene
SELINCRO
N07BB05 -
naloxone
NALOXONE HYDROCHLORIDE (DBL) Pfizer Australia Pty Ltd
V03AB15 -
nemolizumab
NEMLUVIO
D11AH12 -
neratinib
NERLYNX
L01EH02 -
nilotinib
TASIGNA Novartis Pharmaceuticals
L01EA03 -
nipocalimab
IMAAVY
L04AL03 -
niraparib
ZEJULA GlaxoSmithKline
L01 -
nirogacestat
OGSIVEO
L01XX81 -
nirsevimab
BEYFORTUS
J06BD08 -
nogapendekin alfa inbakicept
ANKTIVA
L03AC03 -
nomegestrol
ZOELY
G03AA14 -
nonacog alfa
BENEFIX
B02BD04 -
nonacog beta pegol
REFIXIA
B02BD04 -
nonacog gamma
RIXUBIS
B02BD04 -
norelgestromin
EVRA
G03AA13 -
nusinersen
SPINRAZA Biogen
M09 -
octreotide
OCTREOTIDE (SUN) Novartis Pharmaceuticals
H01CB02 -
oestrogens conjugated
DUAVIVE
G03CC07 -
olezarsen
TRYNGOLZA
C10AX -
olipudase alfa
XENPOZYME
A16AB25
Frequently asked questions
How many ema approved drugs are listed?
931 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.